1. Home
  2. GHRS vs OLO Comparison

GHRS vs OLO Comparison

Compare GHRS & OLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • OLO
  • Stock Information
  • Founded
  • GHRS 2018
  • OLO 2005
  • Country
  • GHRS Ireland
  • OLO United States
  • Employees
  • GHRS N/A
  • OLO N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • OLO Major Banks
  • Sector
  • GHRS Health Care
  • OLO Finance
  • Exchange
  • GHRS Nasdaq
  • OLO Nasdaq
  • Market Cap
  • GHRS 849.8M
  • OLO 1.0B
  • IPO Year
  • GHRS 2021
  • OLO 2021
  • Fundamental
  • Price
  • GHRS $12.06
  • OLO $8.92
  • Analyst Decision
  • GHRS Strong Buy
  • OLO Buy
  • Analyst Count
  • GHRS 8
  • OLO 3
  • Target Price
  • GHRS $30.63
  • OLO $9.00
  • AVG Volume (30 Days)
  • GHRS 176.0K
  • OLO 1.3M
  • Earning Date
  • GHRS 05-08-2025
  • OLO 07-30-2025
  • Dividend Yield
  • GHRS N/A
  • OLO N/A
  • EPS Growth
  • GHRS N/A
  • OLO N/A
  • EPS
  • GHRS N/A
  • OLO 0.01
  • Revenue
  • GHRS N/A
  • OLO $299,107,000.00
  • Revenue This Year
  • GHRS N/A
  • OLO $20.21
  • Revenue Next Year
  • GHRS N/A
  • OLO $17.90
  • P/E Ratio
  • GHRS N/A
  • OLO $839.56
  • Revenue Growth
  • GHRS N/A
  • OLO 23.31
  • 52 Week Low
  • GHRS $6.00
  • OLO $4.20
  • 52 Week High
  • GHRS $20.50
  • OLO $9.78
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 52.59
  • OLO 52.76
  • Support Level
  • GHRS $11.50
  • OLO $8.47
  • Resistance Level
  • GHRS $12.94
  • OLO $8.94
  • Average True Range (ATR)
  • GHRS 0.98
  • OLO 0.29
  • MACD
  • GHRS -0.14
  • OLO -0.04
  • Stochastic Oscillator
  • GHRS 32.73
  • OLO 47.53

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About OLO Olo Inc.

Olo Inc is an open Software as a Service platform for restaurants. Its platform powers restaurant brands' on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants' direct guest relationships. The company generates revenue from providing its customers access to its platform.

Share on Social Networks: